These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Double-blind clinical trial of a new coronary-active drug, MD 6753]. Dalla Volta S. Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049 [No Abstract] [Full Text] [Related]
8. [Place and value of the maleate of ethyl cinepazate (vascoril) among the anti-angina agents]. Garbarg S. Boll Soc Ital Cardiol; 1976 Oct; 21(9):1735-7. PubMed ID: 1031333 [No Abstract] [Full Text] [Related]
9. [Long-term treatment of coronary insufficiency with 6753 M.D. (ethyl cinepazate maleate)]. Neirinck M, Parent J, Frère A. Brux Med; 1973 Jun; 53(6):397-400. PubMed ID: 4727316 [No Abstract] [Full Text] [Related]
10. Trimetazidine in the treatment of angina pectoris. Mehrotra TN, Bassadone ET. Br J Clin Pract; 1967 Nov 11; 21(11):553-4. PubMed ID: 4864732 [No Abstract] [Full Text] [Related]
15. [A new drug for the therapy of angina pectoris and coronary insufficiency: Lidoflazine (R 7904)]. Dziuba K. Med Welt; 1967 Apr 08; 14():894-9. PubMed ID: 5585086 [No Abstract] [Full Text] [Related]
16. [Clinical electrocardiographic and ergometric studies on the efficiency of lidoflazine in angina pectoris]. Schwalb H. Arzneimittelforschung; 1971 Apr 08; 21(4):465-72. PubMed ID: 5108141 [No Abstract] [Full Text] [Related]